{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:40:39Z","timestamp":1785829239123,"version":"3.56.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974507"],"award-info":[{"award-number":["81974507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bioorg.2023.106405","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:19:18Z","timestamp":1675372758000},"page":"106405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Pharmacological evaluation of a novel skeleton compound isobavachin (4\u2032,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1\/GLUT9 and xanthine oxidase inhibitory activity"],"prefix":"10.1016","volume":"133","author":[{"given":"Zean","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106405_b0005","author":"Dalbeth","year":"2021","journal-title":"Gout Lancet"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106405_b0010","first-page":"760","article-title":"Hyperuricemia and gout; the role of diet","volume":"29","author":"Alvarez-Lario","year":"2014","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.bioorg.2023.106405_b0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat. Commun."},{"issue":"59","key":"10.1016\/j.bioorg.2023.106405_b0020","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/j.ackd.2012.07.009","article-title":"Renal transport of uric acid: evolving concepts and uncertainties","volume":"19","author":"Bobulescu","year":"2012","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106405_b0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00424-020-02411-3","article-title":"Structure, function and regulation of mammalian glucose transporters of the SLC2 family","volume":"472","author":"Holman","year":"2020","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bioorg.2023.106405_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","article-title":"Structural biology of the major facilitator superfamily transporters","volume":"44","author":"Yan","year":"2015","journal-title":"Annu. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: a systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0045","first-page":"173","article-title":"Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis","volume":"15","author":"Ristic","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14728222.2018.1420167","article-title":"ABCG2 as a therapeutic target candidate for gout","volume":"22","author":"Fujita","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6887","key":"10.1016\/j.bioorg.2023.106405_b0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","article-title":"Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia","volume":"83","author":"Matsuo","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0065","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar4417","article-title":"Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects","volume":"15","author":"Flynn","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106405_b0070","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/art.40583","article-title":"New perspectives in rheumatology: implications of the cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular morbidities trial and the associated food and drug administration public safety alert","volume":"70","author":"Choi","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.ASN.0000107560.80107.19","article-title":"Function and localization of urate transporter 1 in mouse kidney","volume":"15","author":"Hosoyamada","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2023.106405_b0085","first-page":"129","article-title":"ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches","volume":"10","author":"Cleophas","year":"2017","journal-title":"Pharmgenomics. Pers Med."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0090","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1038\/s41598-021-86662-9","article-title":"Hypouricemic agents reduce indoxyl sulfate excretion by inhibiting the renal transporters OAT1\/3 and ABCG2","volume":"11","author":"Taniguchi","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106405_b0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/13543776.2019.1676727","article-title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016\u20132019)","volume":"29","author":"Dong","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-016-1107-x","article-title":"Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney","volume":"18","author":"Miner","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41598-017-00706-7","article-title":"Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout","volume":"7","author":"Tan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.115.231647","article-title":"Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 lowered plasma urate in tufted capuchin monkeys to a greater extent than benzbromarone","volume":"357","author":"Ahn","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2023.106405_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000484279","article-title":"Time to target uric acid to retard chronic kidney disease progression","volume":"192","author":"Uchida","year":"2018","journal-title":"Contrib. Nephrol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106405_b0120","doi-asserted-by":"crossref","first-page":"E831","DOI":"10.1152\/ajpendo.00296.2009","article-title":"Facilitative glucose transporter 9, a unique hexose and urate transporter","volume":"297","author":"Doblado","year":"2009","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.bioorg.2023.106405_b0125","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.pmed.0050197","article-title":"SLC2A9 is a high-capacity urate transporter in humans","volume":"5","author":"Caulfield","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.bioorg.2023.106405_b0130","article-title":"CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia","author":"Zhao","year":"2021","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.bioorg.2023.106405_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114092","article-title":"Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia","volume":"229","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106405_b0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543776.2014.895325","article-title":"Analysis of patents on anti-gout therapies issued in China","volume":"24","author":"Yuan","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2023.106405_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jep.2014.09.034","article-title":"Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice","volume":"157","author":"Wu","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106405_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.18433\/J3Q30H","article-title":"Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice","volume":"13","author":"Wang","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106405_b0155","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.fct.2011.04.029","article-title":"Effects of genistein, apigenin, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice","volume":"49","author":"Huang","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2023.106405_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153374","article-title":"Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase","volume":"80","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2023.106405_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105444","article-title":"Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation","volume":"117","author":"Chen","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106405_b0170","first-page":"404","article-title":"Effect of isopsoralen on the proliferation and differentiate of osteoblasts in vitro","volume":"34","author":"Ming","year":"2011","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.bioorg.2023.106405_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nen087","article-title":"Screening antitumor compounds psoralen and isopsoralen from psoralea corylifolia L","author":"Wang","year":"2011","journal-title":"Seeds, Evid. Based Complement Alternat. Med."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0180","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ptr.972","article-title":"Antioxidative components of Psoralea corylifolia (Leguminosae)","volume":"16","author":"Haraguchi","year":"2002","journal-title":"Phytother. Res."},{"issue":"51","key":"10.1016\/j.bioorg.2023.106405_b0185","doi-asserted-by":"crossref","first-page":"33421","DOI":"10.1021\/acsomega.0c05360","article-title":"Structural insights into the atomistic mechanisms of uric acid recognition and translocation of human urate anion transporter 1","volume":"5","author":"Zhao","year":"2020","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bioorg.2023.106405_b0190","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/2472555220949501","article-title":"Characterizations of the Urate Transporter, GLUT9, and Its Potent Inhibitors by Patch-Clamp Technique","volume":"26","author":"Chen","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.bioorg.2023.106405_b0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fphar.2016.00518","article-title":"Identification of Febuxostat as a New Strong ABCG2 inhibitor: potential applications and risks in clinical situations","volume":"7","author":"Miyata","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106405_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153585","article-title":"Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt\/beta-catenin pathway","volume":"87","author":"Li","year":"2021","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.bioorg.2023.106405_b0205","doi-asserted-by":"crossref","first-page":"e108852","DOI":"10.1371\/journal.pone.0108852","article-title":"Expression, purification, and structural insights for the human uric acid transporter, GLUT9, using the Xenopus laevis oocytes system","volume":"9","author":"Clemencon","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/dmd.106.012187","article-title":"Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells","volume":"35","author":"Yu","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bioorg.2023.106405_b0215","doi-asserted-by":"crossref","first-page":"F612","DOI":"10.1152\/ajprenal.00139.2009","article-title":"Mouse GLUT9: evidences for a urate uniporter","volume":"297","author":"Bibert","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.bioorg.2023.106405_b0220","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.pharep.2017.06.012","article-title":"Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)","volume":"69","author":"Wu","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"15","key":"10.1016\/j.bioorg.2023.106405_b0225","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/elps.202000083","article-title":"Evaluation of xanthine oxidase inhibitory activity of flavonoids by an online capillary electrophoresis-based immobilized enzyme microreactor","volume":"41","author":"Wu","year":"2020","journal-title":"Electrophoresis"},{"key":"10.1016\/j.bioorg.2023.106405_b0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijbiomac.2018.01.190","article-title":"Mechanistic insights into the inhibition of quercetin on xanthine oxidase","volume":"112","author":"Zhang","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.bioorg.2023.106405_b0235","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/bpb.30.1551","article-title":"Hypouricemic action of selected flavonoids in mice: structure-activity relationships","volume":"30","author":"Mo","year":"2007","journal-title":"Biol. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.bioorg.2023.106405_b0240","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/rheumatology\/key100","article-title":"Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study","volume":"57","author":"Shiramoto","year":"2018","journal-title":"Rheumatol. (Oxford)"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106405_b0245","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/rheumatology\/kez196","article-title":"Gout and hyperuricaemia in the USA: prevalence and trends","volume":"58","author":"Singh","year":"2019","journal-title":"Rheumatol. (Oxford)"},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41584-018-0149-7","article-title":"Prevention and treatment of gout","volume":"15","author":"Stamp","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am. J. Med."},{"issue":"34","key":"10.1016\/j.bioorg.2023.106405_b0260","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.1021\/acs.jafc.0c03848","article-title":"\u201cKidney Tea\u201d and Its bioactive secondary metabolites for treatment of gout","volume":"68","author":"Chen","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2023.106405_b0265","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.1021\/acs.jmedchem.0c00223","article-title":"Novel Human Urate Transporter 1 inhibitors as hypouricemic drug candidates with favorable druggability","volume":"63","author":"Zhao","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106405_b0270","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.jmedchem.1c02057","article-title":"Discovery of Novel Bicyclic Imidazolopyridine-Containing Human Urate Transporter 1 inhibitors as hypouricemic drug candidates with improved efficacy and favorable druggability","volume":"65","author":"Zhao","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106405_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114816","article-title":"Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors","volume":"244","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106405_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114682","article-title":"Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents","volume":"242","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/BOR.0b013e32833645e8","article-title":"Genetics of gout","volume":"22","author":"Choi","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0290","doi-asserted-by":"crossref","first-page":"e00291","DOI":"10.1002\/prp2.291","article-title":"Uricosuric targets of tranilast","volume":"5","author":"Mandal","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"issue":"18","key":"10.1016\/j.bioorg.2023.106405_b0295","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1039\/D1FO00538C","article-title":"Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model via the regulation of uric acid metabolism","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"issue":"18","key":"10.1016\/j.bioorg.2023.106405_b0300","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1021\/bi002841o","article-title":"Arginine 454 and lysine 370 are essential for the anion specificity of the organic anion transporter, rOAT3","volume":"40","author":"Feng","year":"2001","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106405_b0305","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/jphp.13337","article-title":"Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases","volume":"72","author":"Xing","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106405_b0310","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/IJN.S158585","article-title":"Preparation, characterization and systemic application of self-assembled hydroxyethyl starch nanoparticles-loaded flavonoid Morin for hyperuricemia therapy","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jphp.12492","article-title":"Biodistribution, hypouricemic efficacy and therapeutic mechanism of morin phospholipid complex loaded self-nanoemulsifying drug delivery systems in an experimental hyperuricemic model in rats","volume":"68","author":"Zhang","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106405_b0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s13318-018-0509-3","article-title":"Pharmacokinetics and bioavailability enhancement of baicalin: a review","volume":"44","author":"Huang","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"36","key":"10.1016\/j.bioorg.2023.106405_b0325","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1021\/acs.jafc.9b01795","article-title":"Natural flavones from morus alba against methicillin-resistant staphylococcus aureus via targeting the proton motive force and membrane permeability","volume":"67","author":"Wu","year":"2019","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106405_b0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.toxlet.2005.11.007","article-title":"Effects of natural prenylated flavones in the phenotypical ER (+) MCF-7 and ER (-) MDA-MB-231 human breast cancer cells","volume":"164","author":"Pedro","year":"2006","journal-title":"Toxicol. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:40:56Z","timestamp":1758616856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":66,"alternative-id":["S0045206823000652"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106405","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evaluation of a novel skeleton compound isobavachin (4\u2032,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1\/GLUT9 and xanthine oxidase inhibitory activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106405"}}